<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940114-2-00079</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=56 g=1 f=1 -->  <DOCTITLE>National Toxicology Program; Availability of Technical Report on Toxicology and Carcinogenesis Studies of Acetaminophen </DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The HHS' National Toxicology Program announces the availability of the NTP Technical Report on the toxicology and carcinogenesis studies of acetaminophen, which is a widely consumed analgesic found in several nonprescription pharmaceuticals.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Two-year toxicology and carcinogenesis studies were conducted by administering to both sexes of rats and mice doses of 0, 600, 3,000, or 6,000 ppm acetaminophen in feed for 104 weeks.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Under the conditions of these 2-year feed studies, there was no evidence of carcinogenic activity&sect; <FOOTCITE>1</FOOTCITE>  of acetaminophen in male F344/N rats that received 600, 3,000, or 6,000 ppm. There was equivocal evidence of carcinogenic activity of acetaminophen in female F344/N rats based on increased incidences of mononuclear cell leukemia. There was no evidence of carcinogenic activity of acetaminophen in male and female B6C3F1 mice that received 600, 3,000, or 6,000 ppm.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <FOOTNOTE> <FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> 1 <!-- PJG /ITAG -->  </FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> The NTP uses five categories of evidence of carcinogenic activity observed in each animal study: two categories for positive results (``clear evidence'' and ``some evidence''), one category for uncertain findings (``equivocal evidence''), one category for no observable effect (``no evidence''), and one category for studies that cannot be evaluated because of major flaws (``inadequate study'').  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </FOOTNOTE>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Nonneoplastic lesions associated with exposure to acetaminophen included increased severity of nephropathy and increased incidences of renal tubule hyperplasia and parathyroid hyperplasia in male rats, increased severity of nephropathy in female rats, and increased incidences of thyroid follicular cell hyperplasia in male and female mice.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Questions or comments about the Technical Report should be directed to Central Data Management at P.O. Box 12233, Research Triangle Park, NC 27709 or telephone (919) 541&hyph;3419.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Copies of Toxicology and Carcinogenesis Studies of Acetaminophen (CAS No. 103&hyph;90&hyph;2) in F344/N Rats and B6C3F1 Mice (Feed Studies) (TR&hyph;394) are available without charge from Central Data Management, NIEHS, MD A0&hyph;01, P.O. Box 12233, Research Triangle Park, NC 27709; telephone (919) 541&hyph;3419. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: January 7, 1994.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Kenneth Olden,  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Director, National Toxicology Program.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;909 Filed 1&hyph;13&hyph;94; 8:45 am]  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4140&hyph;01&hyph;M  <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            